NEW YORK (360Dx) – Guardant Health said this week that it closed an initial public offering of approximately 14.4 million shares of its common stock at $19 per share, raising gross proceeds of about $273.1 million. The number of shares offered included the exercise in full of the underwriters’ option to purchase an additional 1.9 million shares of the company’s stock. JP Morgan and Bank of America Merrill Lynch were joint book-running managers for the offering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.